Kim Mallard

2.5k citations

26 papers · 1.3k indexed · 1 hit paper · h-index 17

Co-authors: Ruth McNerney Taane G. Clark Francesc Coll José Afonso Guerra‐Assunção Judith R. Glynn Julian Parkhill Amelia C. Crampin Arnab Pain
Topics: Tuberculosis Research and Epidemiology (19 papers)Mycobacterium research and diagnosis (18 papers)Diagnosis and treatment of tuberculosis (9 papers)
Cited by: Infectious Diseases Epidemiology Molecular Medicine
Journals: Journal of Clinical Oncology Bioinformatics PLoS ONE
Partner nations: United Kingdom Australia Saudi Arabia

In The Last Decade

Kim Mallard

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences

2015 282 citations Francesc Coll, Ruth McNerney et al. Genome Medicine profile →

Peers

Countries citing papers authored by Kim Mallard

Since Specialization

Citations

This map shows the geographic impact of Kim Mallard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Mallard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Mallard more than expected).

Fields of papers citing papers by Kim Mallard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Mallard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Mallard. The network helps show where Kim Mallard may publish in the future.

Co-authorship network of co-authors of Kim Mallard

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Mallard. A scholar is included among the top collaborators of Kim Mallard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Mallard. Kim Mallard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres 2023 ·BMJ Open ·Dean A. Fennell,Daniel E. Griffiths,Zina Eminton,(unknown),Kayleigh Hill,Sean Ewings,(unknown),Lucy Johnson,Kim Mallard,(unknown),Liz Darlison,Sean Dulloo,Judith Cave,Jinli Luo,Paul Taylor,(unknown),Charlotte Poile,(unknown),Gareth Griffiths	2
2	Identifying mixed Mycobacterium tuberculosis infections from whole genome sequence data 2018 ·BMC Genomics ·Benjamin Sobkowiak,Judith R. Glynn,Rein M G J Houben,Kim Mallard,Jody Phelan,José Afonso Guerra‐Assunção,Louis Banda,Themba Mzembe,Miguel Viveiros,Ruth McNerney,Julian Parkhill,Amelia C. Crampin,Taane G. Clark	48
3	Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance 2016 ·BMC Medicine ·Jody Phelan,Francesc Coll,Ruth McNerney,David B. Ascher,Douglas E. V. Pires,Nicholas Furnham,Nele Coeck,Grant Hill-Cawthorne,Mridul Nair,Kim Mallard,Andrew Ramsay,Susana Campino,Martin L. Hibberd,Arnab Pain,Leen Rigouts,Taane G. Clark	88
4	Characterization of genomic variations in SNPs of PE_PGRS genes reveals deletions and insertions in extensively drug resistant (XDR) M. tuberculosis strains from Pakistan 2015 ·International Journal of Mycobacteriology ·Akbar Kanji,Zahra Hasan,Asho Ali,Ruth McNerney,Kim Mallard,Francesc Coll,Grant Hill-Cawthorne,Mridul Nair,Taane G. Clark,(unknown),(unknown),Rumina Hasan	6
5	Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesbreakdown → 2015 ·Genome Medicine ·Francesc Coll,Ruth McNerney,Mark D. Preston,José Afonso Guerra‐Assunção,Andrew Warry,Grant Hill-Cawthorne,Kim Mallard,Mridul Nair,Anabela Miranda,Adriana Alves,João Perdigão,Miguel Viveiros,Isabel Portugal,Zahra Hasan,Rumina Hasan,Judith R. Glynn,Nigel Martin,Arnab Pain,Taane G. Clark	282
6	Whole Genome Sequencing Based Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Isolates from Pakistan 2015 ·PLoS ONE ·Asho Ali,Zahra Hasan,Ruth McNerney,Kim Mallard,Grant Hill-Cawthorne,Francesc Coll,Mridul Nair,Arnab Pain,Taane G. Clark,Rumina Hasan	88
7	Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area 2015 ·eLife ·José Afonso Guerra‐Assunção,Amelia C. Crampin,(unknown),Themba Mzembe,Kim Mallard,Francesc Coll,Palwasha Khan,Louis Banda,Arthur Chiwaya,(unknown),Ruth McNerney,(unknown),Julian Parkhill,Taane G. Clark,(unknown)	174
8	Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting 2014 ·BMC Genomics ·João Perdigão,Hugo Silva,Diana Machado,Rita Macedo,Fernando Maltêz,Carla Silva,Luísa Jordão,Isabel Couto,Kim Mallard,Francesc Coll,Grant Hill-Cawthorne,Ruth McNerney,Arnab Pain,Taane G. Clark,Miguel Viveiros,Isabel Portugal	43
9	A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture 2014 ·FEMS Microbiology Letters ·Indra Bergval,Francesc Coll,Anja Schuitema,Hans de Ronde,Kim Mallard,Arnab Pain,Ruth McNerney,Taane G. Clark,Richard Anthony	9
10	Recurrence due to Relapse or Reinfection WithMycobacterium tuberculosis: A Whole-Genome Sequencing Approach in a Large, Population-Based Cohort With a High HIV Infection Prevalence and Active Follow-up 2014 ·The Journal of Infectious Diseases ·José Afonso Guerra‐Assunção,Rein M G J Houben,Amelia C. Crampin,Themba Mzembe,Kim Mallard,Francesc Coll,Palwasha Khan,Louis Banda,Arthur Chiwaya,Rui P. A. Pereira,Ruth McNerney,David Harris,Julian Parkhill,Taane G. Clark,Judith R. Glynn	130
11	Elucidating Emergence and Transmission of Multidrug-Resistant Tuberculosis in Treatment Experienced Patients by Whole Genome Sequencing 2013 ·PLoS ONE ·Taane G. Clark,Kim Mallard,Francesc Coll,Mark D. Preston,Samuel Assefa,David Harris,Sam Ogwang,Francis Mumbowa,Bruce Kirenga,Denise M. O’Sullivan,Alphonse Okwera,Kathleen D. Eisenach,Moses Joloba,Stephen D. Bentley,Jerrold J. Ellner,Julian Parkhill,Edward C. Jones‐López,Ruth McNerney	56
12	SpolPred: rapid and accurate prediction of Mycobacterium tuberculosis spoligotypes from short genomic sequences 2012 ·Bioinformatics ·Francesc Coll,Kim Mallard,Mark D. Preston,Stephen D. Bentley,Julian Parkhill,Ruth McNerney,Nigel Martin,Taane G. Clark	75
13	Production of volatile organic compounds by mycobacteria 2012 ·FEMS Microbiology Letters ·Ruth McNerney,Kim Mallard,(unknown),Claire Turner	37
14	Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs 2011 ·BMC Infectious Diseases ·(unknown),Imad Fadl-Elmula,M. Sanni Ali,(unknown),(unknown),Kim Mallard,Christian Bottomley,Ruth McNerney	59
15	Changes in Mycobacterium tuberculosis Genotype Families Over 20 Years in a Population-Based Study in Northern Malawi 2010 ·PLoS ONE ·Judith R. Glynn,Saad Alghamdi,Kim Mallard,Ruth McNerney,(unknown),(unknown),Rein M G J Houben,Paul Fine,Neil French,Amelia C. Crampin	22
16	Molecular Detection of Mixed Infections of Mycobacterium tuberculosis Strains in Sputum Samples from Patients in Karonga District, Malawi 2010 ·Journal of Clinical Microbiology ·Kim Mallard,Ruth McNerney,Amelia C. Crampin,Rein M G J Houben,(unknown),(unknown),Robin M. Warren,Neil French,Judith R. Glynn	55
17	Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda 2007 ·Annals of Clinical Microbiology and Antimicrobials ·Hamidou Traore,Sam Ogwang,Kim Mallard,Moses Joloba,Francis Mumbowa,(unknown),(unknown),Edward C. Jones‐López,Peter G. Smith,Jerrold J. Ellner,Roy D. Mugerwa,Kathleen D. Eisenach,Ruth McNerney	43
18	Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum 2004 ·Journal of Microbiological Methods ·Kim Mallard,K Schopfer,Thomas Bodmer	46
19	Detection of heat-stable enterotoxin genes among AustralianVibrio choleraeO1 strains 1995 ·FEMS Microbiology Letters ·Kim Mallard,Patricia Desmarchelier	8
20	An epidemiological study ofVibrio choleraeO1 in the Australian environment based on rRNA gene polymorphisms 1995 ·Epidemiology and Infection ·Patricia Desmarchelier,Frank Wong,Kim Mallard	14

About Kim Mallard

Kim Mallard is a scholar working on Infectious Diseases, Epidemiology and Endocrinology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (18 papers) and Diagnosis and treatment of tuberculosis (9 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Epidemiology (1.0k citations) and Molecular Medicine (124 citations). Kim Mallard has collaborated with scholars based in United Kingdom, Australia and Saudi Arabia. Frequent co-authors include Ruth McNerney, Taane G. Clark, Francesc Coll, José Afonso Guerra‐Assunção, Judith R. Glynn, Julian Parkhill, Amelia C. Crampin, Arnab Pain, Grant Hill-Cawthorne and Ruth McNerney. Their work appears in journals such as Journal of Clinical Oncology, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact